ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 28, 2025

A very instructive case that Dr. Shaw discussed involved a middle-aged woman who presented with erythematous annular and indurated plaques on her face, trunk and extremities and had false-positive syphilis test results during two pregnancies much earlier in life. Testing at the time of presentation showed a high-titer positive rapid plasma reagin (RPR). Although the Poll Everywhere results indicated that the audience thought the positive RPR was a false positive due to anticardiolipin antibodies, Dr. Shaw explained that secondary syphilis was the correct diagnosis as a false positive RPR should be low titer when occurring in the setting of antiphospholipid antibodies. After demonstrating a positive fluorescent treponemal antibody absorption (FTA-ABS) test and with a skin biopsy showing numerous spirochetes, the patient was treated with one dose of intramuscular penicillin G and the patient’s rash was nearly resolved.

Gout

Dr. Gaffo

Dr. Gaffo

The next speaker, Angelo Gaffo, MD, MSPH, section chief of rheumatology at the Birmingham VA Medical Center and associate professor of medicine in the Division of Rheumatology at the University of Alabama at Birmingham, lectured on gout, a condition that affects about 5% of the U.S. population.2 Although rheumatologists often think of this crystalline arthritis affecting joints, Dr. Gaffo noted that the dorsum of the feet and hands and even the sacroiliac joints can be involved as well. Similarly, although the intercritical periods of gout are typically asymptomatic for patients, individuals with advanced gout may experience pain and stiffness even between true gout flares.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Gaffo implored clinicians not to be fooled by a seemingly normal or low serum uric acid level during an acute flare, when the active inflammatory process can cause a uricosuric effect and result in this misleadingly low urate level. Although radiographs continue to be helpful in diagnosis, especially if the classic rat bite erosions or tophi are visualized, other imaging modalities are of great help as well. Ultrasound of a joint that has been affected by gout can reveal the double contour sign, an echogenic line on the outer surface of the joint cartilage running parallel to the subchondral bone; this occurs secondary to deposition of monosodium urate (MSU) crystals on the surface of hyaline articular cartilage. Dr. Gaffo is a proponent of dual-energy computed tomography (DECT) scans in cases where a crystal-proven diagnosis has not been obtained and where diagnostic uncertainty exists. DECT scans are fast, do not require contrast and can detect MSU deposition even in intercritical periods of the disease, although Dr. Gaffo warned that DECT scans may be less helpful early in the disease course when less MSU deposition has occurred.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ACR ConvergenceAmerican College of RheumatologyGout and Crystalline ArthritisMeeting ReportsOther Rheumatic ConditionsSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025GoutLupusmacrophage activation syndromeMethotrexatesystemic lupus erythematosus (SLE)Vasculitis

Related Articles
    IgG4-Related Kidney Disease: Diagnostics, Manifestations, & More

    IgG4-Related Kidney Disease: Diagnostics, Manifestations & More

    May 17, 2018

    Immunoglobin G4-related disease (IgG4-RD) is a rare fibro-inflammatory disease of unknown etiology that has been recently recognized. It can cause fibro-inflammatory masses in almost every organ of the body and is associated with dense lymphoplasmacytic infiltration of IgG4-postitive plasma cells, storiform fibrosis and elevated levels of serum IgG4.1 IgG4-RD is a systemic disease that may…

    A Spotlight on IgG4-Related Disease

    January 1, 2013

    What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

    Macrophage Activation Syndrome

    December 1, 2010

    A review of diagnosis, treatment, and prognosis

    New Criteria Released for Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis

    August 10, 2016

    Although most systemic juvenile idiopathic arthritis patients don’t develop macrophage activation syndrome (MAS), the approximately 10% who do have this serious complication can experience widespread, massive inflammation, debilitating symptoms and even death. To improve understanding of MAS among physicians and advance efforts to develop effective therapies to treat it, a panel of 28 international pediatric…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences